Ukr.Biochem.J. 2015; Volume 87, Issue 5, Sep-Oct, pp. 72-82

doi: https://doi.org/10.15407/ubj87.05.072

The role of reactive oxygen species in tumor cells apoptosis induced by landomycin A

20.10.2015   Uncategorized   No comments

L. V. Lehka1, R. R. Panchuk1, W. Berger2, Ju. Rohr3, R. S. Stoika1

1Institute of Cell Biology, National Academy of Sciences of Ukraine, Lviv;
2Institute of Cancer Research, Medical University of Vienna, Austria;
3Department of Pharmaceutical Sciences, University of Kentucky, USA;
e-mail: lilyalehka@gmail.com

Landomycin A (LA) is a new antitumor antibiotic of angucycline group, possessing high antitumor activity against cancer cells of different origin, which induces early apoptosis in target cells. It was shown that under LA action the level of reactive oxygen species (ROS) in human T-leukemia cells had increased 5.6 times in comparison to control already at the 1st hour after the addition of studied antibiotic to the culture medium. At the 6th hour after incubation of cells with LA the nucleosomal DNA cleavage, chromatin condensation and nucleus fragmentation were observed, indicating apoptotic cell death. Catalase (scavenger of hydrogen peroxide), mannitol (scavenger of hydroxyl radicals) and superoxide dismutase (scavenger of superoxide radicals) reduced the level of ROS production under LA, suggesting the generation of H2O2, OH• and O2– radicals, respectively. It was revealed that catalase and mannitol effectively inhibited LA-mediated tumor cell death, increasing 2.5 times the percentage of alive cells in comparison to LA. However, superoxide dismutase had no significant inhibitory effect on cytotoxic activity of LA, indicating the minor role of superoxide anions in the implementation of antitumor activity of this antibiotic. Combination of catalase, mannitol and superoxide dismutase with LA increased 4-fold the percentage of alive cells in comparison to the action of LA. Dynamics of ROS formation confirms that the increase of ROS is a very rapid process, but at the same time it is not a direct consequence of apoptosis triggering, mediated by mitochondria.

Keywords: , , ,

References:

  1. Kong Q, Beel JA, Lillehei KO. A threshold concept for cancer therapy. Med Hypotheses. 2000 Jul;55(1):29-35. Review. PubMed, CrossRef
  2. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009 Jul;8(7):579-91. Review. PubMed, CrossRef
  3. Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013 Dec;12(12):931-47. PubMed,  CrossRef
  4. Manuel M, Mario DC. Oxidative Stress and Diseases. InTech, 2012. 519 p.
  5. Ostash B, Korynevska A, Stoika R, Fedorenko V. Chemistry and biology of landomycins, an expanding family of polyketide natural products.  Mini Rev Med Chem. 2009 Aug;9(9):1040-51. PubMed,  CrossRef
  6. Adams R.  Laboratory techniques in biochemistry and molecular biology. Elsevier. 1990. P. 16-94.
  7. Freshney RI. Culture of animal cells: a manual of basic technique and specialized applications, 6th edition. Wiley-Backwell, 2010. 768 p.
  8. Ziegler U, Groscurth P. Morphological features of cell death. News Physiol Sci. 2004 Jun;19(3):124-8. Review. PubMed,  CrossRef
  9. Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. 2000 Feb;45(3):528-37. Review. PubMed,  CrossRef
  10. Nagata S. Apoptotic DNA fragmentation. Exp Cell Res. 2000 Apr 10;256(1):12-8. Review. PubMed,  CrossRef
  11. Matassov D, Kagan T, Leblanc J, Sikorska M, Zakeri Z. Measurement of apoptosis by DNA fragmentation. Methods Mol Biol. 2004;282:1-17. PubMed
  12. Noriko N, Wakasugi H. Cancer and Oxidative Stress. J Japan Med Assoc. 2000;124(11):1571-1574.
  13. Manda G, Nechifor M, Neagu T-M. Reactive Oxygen Species, Cancer and Anti-Cancer Therapies. Curr Chem Biol. 2009 Jan;3(1):22-46.  CrossRef
  14. Conklin KA. Cancer chemotherapy and antioxidants. J Nutr. 2004 Nov;134(11):3201S-3204S. PubMed
  15. Deavall DG, Martin EA, Horner JM, Roberts R. Drug-induced oxidative stress and toxicity. J Toxicol. 2012;2012:645460. PubMed, PubMedCentral, CrossRef
  16. Nuydens R, Novalbos J, Dispersyn G, Weber C, Borgers M, Geerts H. A rapid method for the evaluation of compounds with mitochondria-protective properties. J Neurosci Methods. 1999 Oct 15;92(1-2):153-9. PubMed,  CrossRef
  17. Conklin KA. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther. 2004 Dec;3(4):294-300. PubMed, CrossRef
  18. Angsutararux P, Luanpitpong S, Issaragrisil S. Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress. Oxidative Medicine and Cellular Longevity.  2015. P. 1-13.
  19. Minotti G, Menna P, Salvatorelly  E, Cairo G, Gianti L. Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity. Pharmacol Rev. 2004 Jun;56(2):185-229.  PubMed, CrossRef
  20. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003 Oct 15;552(Pt 2):335-44. Review. PubMed, PubMedCentral
  21. Kirshner JR, He S, Balasubramanyam V, Kepros J, Yang CY, Zhang M, Du Z, Barsoum J, Bertin J. Elesclomol induces cancer cell apoptosis through oxidative stress. Mol Cancer Ther. 2008 Aug;7(8):2319-27. PubMed, CrossRef
Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.